Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 24 May 2023, 15:00 HKT/SGT
Share:
    

Source: Access Accelerated
New Access Accelerated Global Collective Report Charts Path Forward in Fight Against Noncommunicable Diseases
Access Accelerated and Partners Unveil Findings From Six-Year Report

GENEVE, CH, May 24, 2023 - (ACN Newswire) - Access Accelerated, a pioneering collective of leading biopharmaceutical and life science companies dedicated to confronting the growing global noncommunicable disease (NCD) crisis, announced the release of a six-year report: Key Lessons in Advancing Access to NCD Care: Collaboration, Connectivity, Community.

This milestone report highlights the initiative's outcomes, impact, and collective learnings between 2017 and 2022 and serves as a retrospective, a showcase for the initiative's success stories and challenges, and a much-needed vision for the future.

Michael Fredrich, Lead Access to Medicine Non-Communicable Diseases at Bayer Pharmaceuticals and Chair of the Access Accelerated Board, commented, "With the 2030 deadline for the UN Sustainable Development Goals approaching fast, which include Universal Health Coverage, it's more important than ever that we make the most out of our resources and approach this fight strategically. This report gives us the opportunity to critically evaluate our past and use key learnings for the future. It is essential that we share insights and learn from our collective efforts. Much work lies ahead, but this report serves as a valuable foundation for effectively addressing NCDs."

This initiative's impact has already been felt widely. Access Accelerated and its strategic partners - the City Cancer Challenge Foundation, NCD Alliance, PATH, the World Bank and the World Heart Federation - have helped improve access to NCD screening, diagnosis, and treatment around the world, reaching over 700 million people through 54 partner projects in 37 countries and catalyzing $US1.6 billion in investment in 2022 alone. By the end of phase 2 (2020-2022), this number totalled $US3.7 billion. In the same period, Access Accelerated partner projects contributed to policy change in 35 countries and 13 projects were scaled to national level, moving away from pilot phase to locally embedded projects.

Six years since its founding, the initiative has accumulated a wealth of hard-won knowledge and experience. The report highlights those learnings, including the crucial role of open, transparent communication in measuring intangible impact of partnerships, the ways flexible long-term funding can open the way for locally embedded solutions, and why community- and patient-centric approaches are essential to sustainability. By capturing impacts beyond hard numbers, the report demonstrates the importance of local engagement, trust, and social capital in improving NCD outcomes over time.

According to Dr. Juan Pablo Uribe, World Bank's Global Director for Health, Nutrition & Population and Director of the Global Financing Facility, the report demonstrates the importance of rigorous monitoring and reporting. "Learning from our successes and challenges is absolutely necessary if we are going to shape more efficient and effective initiatives that can respond to the growing NCD burden on countries around the world. That's why we're excited to have the insights offered by this report to inform future initiatives and are grateful to the partnership with Access Accelerated which has led to meaningful action in creating sustainable change."

Visit www.accessaccelerated.org to download the report.

About Access Accelerated

Founded in 2017, Access Accelerated is an unprecedented industry-led collective of life science companies united by the belief that no person should die from a preventable and treatable disease. Through the power of collaboration and a proven framework for cooperation, Access Accelerated brings together stakeholders across the private, public and social sectors, including implementers, decision-makers and financiers, in a shared mission of advancing action against the escalating challenge of NCDs in low- and middle-income countries and underserved communities.

Contact Information
Thuy Khuc-Bilon
Communications Manager
info@accessaccelerated.org
+41 79 473 0341


Topic: Press release summary
Source: Access Accelerated

Sectors: BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Graphene Manufacturing Group Ltd. Announces Upsize of Bought Deal Public Offering for Gross Proceeds of C$6 Million  
Aug 22, 2025 23:00 HKT/SGT
Ta Yang Group Holdings Limited Announcing AI Transformation Blueprint  
Aug 22, 2025 19:21 HKT/SGT
CaoCao Inc. (2643.HK) Added to Hang Seng Composite Index, Set to Join Hong Kong Stock Connect on Sept 8  
Aug 22, 2025 18:51 HKT/SGT
CITIC Resources Deepens Dual Driver Development Strategy of "Investment + Trading"  
Aug 22, 2025 18:28 HKT/SGT
Everbright Grand China Achieved Revenue of RMB24.5 Million in 2025 1H  
Aug 22, 2025 13:26 HKT/SGT
China International Development Corporation Limited announces strategic acquisition of 20% stake in NVT  
Aug 22, 2025 08:22 HKT/SGT
TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Successfully Carries Out Space Protein Crystallization Experiments  
Friday, August 22, 2025 2:00:00 AM
Asia's CX Leaders Are Aligning Strategy Around AI, Efficiency, and Workforce Engagement: Key Insights from Customer Experience Live Show Asia 2025  
Aug 21, 2025 22:00 HKT/SGT
NEC digital technologies to empower small-scale producers in Africa in partnership with IFAD  
Thursday, August 21, 2025 7:32:00 PM
Sharp Corporation and Sharp Energy Solutions Corporation Sign Memorandum of Understanding with Mitsui O.S.K. Lines, and AAR Japan for Donation of Solar Modules to Kenya  
Thursday, August 21, 2025 7:15:00 PM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: